FindMyKOL

Chokkalingam Siva, MD

Basic profile

University of Missouri System

ORCIDNone on fileNPIOn fileSign in to see identifiers
RegionColumbia, MO · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2024FindMyKOL typeFindMyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Chokkalingam Siva is a Rheumatology/Immunology physician affiliated with University of Missouri System. OpenAlex indexes 36 publications with 883 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
36publications

Publications indexed by OpenAlex. Counts exclude supporting files.

883citations

Citations across these publications.

14h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • E.R. Squibb & Sons, L.L.C.
    Program year20242 payments
    $30

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    39.6%
    Folate Analog Metabolic Inhibitor15.2%
    Methotrexate100%
    Part D≥16 patients
    TNF inhibitor14%
    Humira(Cf) Pen53%Humira Pen27%Enbrel Mini20%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    31.5%
    Opioid Agonist17.5%
    Tramadol Hcl100%
    Part D≥17 patients
    Gabapentinoids12.1%
    Pregabalin83%Gabapentin17%
    Part D<11 patients

    + 1 more class in this area

  • Antiparasitic

    19%
    Antimalarial19%
    Hydroxychloroquine Sulfate100%
    Part D≥26 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”